Wixela Inhub Interactions
There are 463 drugs known to interact with Wixela Inhub (fluticasone/salmeterol), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 55 are major, 391 are moderate, and 17 are minor.
- View all 463 medications that may interact with Wixela Inhub
- View Wixela Inhub alcohol/food interactions (2)
- View Wixela Inhub disease interactions (11)
Most frequently checked interactions
View interaction reports for Wixela Inhub (fluticasone / salmeterol) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- bupropion
- cetirizine
- famotidine
- fluticasone nasal
- furosemide
- gabapentin
- hydrochlorothiazide
- ibuprofen
- levothyroxine
- lisinopril
- losartan
- metformin
- montelukast
- omeprazole
- pantoprazole
- prednisone
- ProAir HFA (albuterol)
- rosuvastatin
- Spiriva Respimat (tiotropium)
- tamsulosin
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Wixela Inhub alcohol/food interactions
There are 2 alcohol/food interactions with Wixela Inhub (fluticasone / salmeterol).
Wixela Inhub disease interactions
There are 11 disease interactions with Wixela Inhub (fluticasone / salmeterol) which include:
- cardiovascular
- diabetes
- hypokalemia
- seizures
- hepatic impairment
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
- hepatic dysfunction
Report options
QR code containing a link to this page
More about Wixela Inhub (fluticasone / salmeterol)
- Wixela Inhub consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (117)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bronchodilator combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.